AN0025

· Adlai Nortye Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AN0025, covering 2024-06-27 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors [Phase 1]